Home › Funds › APPLETON PARTNERS INC/MA › JNJ

APPLETON PARTNERS INC/MA position in JNJ

JOHNSON & JOHNSON · Health Care

APPLETON PARTNERS INC/MA reported holding 44,537 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$11.8M, representing 0.72% of its reported portfolio and ranking #41 among its reported holdings. APPLETON PARTNERS INC/MA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)44.54K sh
Reported value held$11.79M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How APPLETON PARTNERS INC/MA's JNJ position evolved

APPLETON PARTNERS INC/MA first disclosed a stake in JNJ in Q3 2023 at 59,254 shares (US$9.2M). The position peaked in Q3 2026 at 44,537 shares, worth US$11.8M. Across 13 filings, APPLETON PARTNERS INC/MA increased the stake 1 time(s), trimmed it 9 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 44,537 shares valued at US$11.8M — a reduction of -1,337 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 59.25K $9.23M New
Q4 2023 60.44K $9.47M Add
Q1 2024 57.41K $9.08M Reduce
Q2 2024 56.36K $8.24M Reduce
Q3 2024 55.25K $8.95M Reduce
Q4 2024 49.92K $7.22M Reduce
Q1 2025 48.05K $7.97M Reduce
Q2 2025 46.98K $7.18M Reduce
Q3 2025 47.01K $8.72M Hold
Q4 2025 47.19K $9.77M Hold
Q1 2026 46.58K $11.39M Reduce
Q2 2026 45.87K $11.65M Reduce
Q3 2026 44.54K $11.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has APPLETON PARTNERS INC/MA held JNJ?

APPLETON PARTNERS INC/MA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is APPLETON PARTNERS INC/MA's current position in JNJ?

As of Q3 2026, APPLETON PARTNERS INC/MA holds 44.54K shares of JNJ (JOHNSON & JOHNSON), valued at $11.79M, representing 0.72% of its reported portfolio and ranking #41.

Has APPLETON PARTNERS INC/MA been buying or selling JNJ?

In the latest 13F filing (Q3 2026), APPLETON PARTNERS INC/MA reduced its position in JNJ. The position peaked in Q3 2026 at 44.54K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.